The future is digital, and healthcare is no exception. Whether you’re looking for the next big investment opportunity or startup to join, you won’t want to miss out on digital health.

I’m Scott, Harvard dropout, Forbes 30 Under 30, and digital health entrepreneur. I co-founded Luminopia, where we developed the world’s first prescription digital therapeutic for an eye disease (a VR-based device for lazy eye treatment).

With In Silico, I’ll take you behind the scenes on what you need to know in digital health. This isn’t your typical industry newsletter — we’re going to dive into the weeds to understand how the field works.

Sign up for articles on topics such as:

  • What to expect with the digitization of clinical trials

  • How to think about Apple’s FDA approvals and healthcare strategy

  • Why telemedicine is here to stay

  • What to do with your Livongo / Teladoc stock

Subscribe to In Silico

An insider look at the future of tech and healthcare.

People

Digital health entrepreneur, Forbes 30U30, proud Canadian